Print

O.I.G. Compliance Reporting

OIGThe Inspector-General (IG) at the U.S. Department of Health and Human Services (HHS) recently announced their discovery of evidence indicating that the U.S. Medicare program could be paying twice for prescription drugs for hospice beneficiaries: "Once under the Medicare Part A hospice per diem payments and again under Medicare Part D." Additionally, according to the IG's article, hospice beneficiaries could also be unnecessarily paying co-payments for prescription drugs that should actually be paid under Part D.

 

If and when CMS looks into the double payments, they may be shocked by what they find. According to other info found within the article, the calendar year 2009 data examined by the IG revealed that Medicare Part D paid prescription costs for analgesia, anti-nausea, anti-emetic, laxative, and anti-anxiety drugs; as well as other higher cost prescription meds used to treat terminal diseases like COPD and ALS.

 

Delta Care Rx partners with Hospice clients to support compliance with the CMS Conditions of Participation (CoPs). We will post important information here regarding hot topics in compliance as we do our part in promoting and exhibiting due diligence.

 

Read Delta Care's Press Release regarding the OIG's latest findings at: http://news.yahoo.com/delta-care-rx-comments-article-issued-inspector-general-072807460.html